Metabolomic profile in preschool children with transient wheezing and early onset asthma

Ana Caroline C Dela Bianca Melo1, Décio Medeiros Peixoto2, Ricardo Oliveira Silva2

  • 1Federal University of Pernambuco (UFPE), Av. Prof. Moraes Rego, 1235, Cidade Universitária, Recife, Pernambuco, Brazil; caroldbianca@gmail.com.

Insights

Metabolomic analysis accurately distinguishes persistent from transient wheezing in preschoolers. This early diagnosis method identifies specific metabolites in plasma, aiding in asthma management.

Area of Science:

  • Pediatric Allergy and Immunology
  • Metabolomics
  • Respiratory Medicine

Background:

  • Early diagnosis of childhood asthma remains a significant clinical challenge.
  • Differentiating persistent from transient wheezing in preschoolers is crucial for appropriate management.
  • Metabolomic profiling offers a potential tool for objective diagnostic differentiation.

Purpose of the Study:

  • To investigate the utility of plasma metabolomic analysis in distinguishing persistent wheezing from transient wheezing in preschool children.
  • To identify specific metabolic biomarkers associated with persistent recurrent wheezing.

Main Methods:

  • A case-control study involving 29 children (aged 4-6 years) with recurrent wheezing.
  • Participants were categorized into persistent wheezers and transient wheezers based on clinical criteria.
  • Plasma samples were analyzed using hydrogen-1 Nuclear Magnetic Resonance (NMR) spectroscopy.

Main Results:

  • Metabolomic analysis achieved a 93.1% accuracy in differentiating between persistent and transient wheezers.
  • Persistent wheezers exhibited significantly higher sensitization to aeroallergens and a positive asthma predictive index.
  • Elevated levels of valine, citrate, lipids, and lipoproteins were observed in persistent wheezers.

Conclusions:

  • Plasma metabolomic profiling, particularly 1H NMR spectroscopy, is a promising method for early and accurate diagnosis of persistent asthma in preschoolers.
  • Specific metabolites like valine and citrate, along with lipid profiles, can serve as biomarkers for persistent wheezing.
  • This approach may facilitate timely intervention and improve long-term outcomes for children with asthma.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
599
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
469